Gyeonggi-do Atopy · Asthma Education Information Center in Korea: a key partner in the Korean Asthma Allergy Program

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis are common and cause high socioeconomic burden. Allergic disease is a matter of not just for a patient, but also for a family and the society. The Korean government, the Korean Disease Control and Prevention Agency, started the nationwide asthma and atopic disease prevention and management plan in collaborations with the opinion leaders from the Korean Academy of Asthma, Allergy, and Clinical Immunology, and the Korea Asthma Allergy Foundation since 2007. Seoul Atopy · Asthma Education Information Center was established in 2008 by the Korean Disease Control and Prevention Agency and the Seoul metropolitan government to provide the reliable and accurate information on asthma and allergic diseases. In 2011, Gyeonggi-do Atopy ∙ Asthma Education Information Center was established by the Korean Disease Control and Prevention Agency and the Gyeonggi-do provincial government. The activities of the center are as follows: (1) atopy ∙ asthma-friendly school program, (2) development/distribution of the educational materials, (3) open lectures for the community, patients, their caregivers, older people, nurses, pharmacists, and doctors, (4) collaborations with the Korean Disease Control and Prevention Agency, the Gyeonggi-do provincial government, the office of education, and the public health centers, (5) collaborations with the Gyeonggi-do fire services to educate 119 rescue teams on the allergic emergency conditions, (6) international collaborations. In this article, 10 years of experience and achievement from the Gyeonggi-do Atopy ∙ Asthma Education Information Center were described, especially on the atopy ∙ asthma-friendly school program.

Related collections

Most cited references 17

Record: found
Abstract: found
Article: found

Is Open Access

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Yuan-Pang Wang, Maheswar Satpathy, Mathilde Touvier … (2018)

Summary Background As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. Methods We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between incidence, prevalence, remission, and cause of death rates for each condition. For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated to cause level. We updated the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. GBD 2016 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, low back pain, migraine, age-related and other hearing loss, iron-deficiency anaemia, and major depressive disorder were the five leading causes of YLDs in 2016, contributing 57·6 million (95% uncertainty interval [UI] 40·8–75·9 million [7·2%, 6·0–8·3]), 45·1 million (29·0–62·8 million [5·6%, 4·0–7·2]), 36·3 million (25·3–50·9 million [4·5%, 3·8–5·3]), 34·7 million (23·0–49·6 million [4·3%, 3·5–5·2]), and 34·1 million (23·5–46·0 million [4·2%, 3·2–5·3]) of total YLDs, respectively. Age-standardised rates of YLDs for all causes combined decreased between 1990 and 2016 by 2·7% (95% UI 2·3–3·1). Despite mostly stagnant age-standardised rates, the absolute number of YLDs from non-communicable diseases has been growing rapidly across all SDI quintiles, partly because of population growth, but also the ageing of populations. The largest absolute increases in total numbers of YLDs globally were between the ages of 40 and 69 years. Age-standardised YLD rates for all conditions combined were 10·4% (95% UI 9·0–11·8) higher in women than in men. Iron-deficiency anaemia, migraine, Alzheimer’s disease and other dementias, major depressive disorder, anxiety, and all musculoskeletal disorders apart from gout were the main conditions contributing to higher YLD rates in women. Men had higher age-standardised rates of substance use disorders, diabetes, cardiovascular diseases, cancers, and all injuries apart from sexual violence. Globally, we noted much less geographical variation in disability than has been documented for premature mortality. In 2016, there was a less than two times difference in age-standardised YLD rates for all causes between the location with the lowest rate (China, 9201 YLDs per 100 000, 95% UI 6862–11943) and highest rate (Yemen, 14 774 YLDs per 100 000, 11 018–19 228). Interpretation The decrease in death rates since 1990 for most causes has not been matched by a similar decline in age-standardised YLD rates. For many large causes, YLD rates have either been stagnant or have increased for some causes, such as diabetes. As populations are ageing, and the prevalence of disabling disease generally increases steeply with age, health systems will face increasing demand for services that are generally costlier than the interventions that have led to declines in mortality in childhood or for the major causes of mortality in adults. Up-to-date information about the trends of disease and how this varies between countries is essential to plan for an adequate health-system response.

0 comments Cited 2058 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

A 10 year asthma programme in Finland: major change for the better.

T Haahtela, L E Tuomisto, A Pietinalho … (2006)

A National Asthma Programme was undertaken in Finland from 1994 to 2004 to improve asthma care and prevent an increase in costs. The main goal was to lessen the burden of asthma to individuals and society. The action programme focused on implementation of new knowledge, especially for primary care. The main premise underpinning the campaign was that asthma is an inflammatory disease and requires anti-inflammatory treatment from the outset. The key for implementation was an effective network of asthma-responsible professionals and development of a post hoc evaluation strategy. In 1997 Finnish pharmacies were included in the Pharmacy Programme and in 2002 a Childhood Asthma mini-Programme was launched. The incidence of asthma is still increasing, but the burden of asthma has decreased considerably. The number of hospital days has fallen by 54% from 110 000 in 1993 to 51 000 in 2003, 69% in relation to the number of asthmatics (n = 135 363 and 207 757, respectively), with the trend still downwards. In 1993, 7212 patients of working age (9% of 80 133 asthmatics) received a disability pension from the Social Insurance Institution compared with 1741 in 2003 (1.5% of 116 067 asthmatics). The absolute decrease was 76%, and 83% in relation to the number of asthmatics. The increase in the cost of asthma (compensation for disability, drugs, hospital care, and outpatient doctor visits) ended: in 1993 the costs were 218 million euro which had fallen to 213.5 million euro in 2003. Costs per patient per year have decreased 36% (from 1611 euro to 1031 euro). It is possible to reduce the morbidity of asthma and its impact on individuals as well as on society. Improvements would have taken place without the programme, but not of this magnitude.

0 comments Cited 135 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

Epidemiology of adult asthma in Asia: toward a better understanding

Woo-Jung Song, Min-Gyu Kang, Yoon-Seok Chang … (2014)

Asia is the world's most dynamic area. Asthma is a major chronic disease in Asia, like other continents. However, unlike childhood asthma, the epidemiological burden of asthma in Asian adults has been unclear. Here we reviewed the currently available literatures on the epidemiology of adult asthma in the Asian community populations. Adult asthma prevalence was generally lower in Asian than in Europe, but the increasing trends suggested the disease burden to rise in the near future. However, for better understanding, it may be essential to prepare for the Asian multinational network for the standardization and collaboration of research.

0 comments Cited 61 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Journal ID (nlm-ta): Asia Pac Allergy

Journal ID (iso-abbrev): Asia Pac Allergy

Journal ID (publisher-id): APA

Title: Asia Pacific Allergy

Publisher: Asia Pacific Association of Allergy, Asthma and Clinical Immunology

ISSN (Print): 2233-8276

ISSN (Electronic): 2233-8268

Publication date Collection: January 2021

Publication date (Electronic): 30 January 2021

Volume: 11

Issue: 1

Electronic Location Identifier: e12

Affiliations

[1 ]Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

[2 ]Gyeonggi-do Atopy · Asthma Education Information Center, Seongnam, Korea.

Author notes

Correspondence to Yoon-Seok Chang. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Korea. Tel: +82-31-787-7023, Fax: +82-31-787-4052, addchang@ 123456snu.ac.kr

Author information

Yoon-Seok Chang https://orcid.org/0000-0003-3157-0447

Article

DOI: 10.5415/apallergy.2021.11.e12

PMC ID: 7870373

SO-VID: c6e916c7-9344-4ae9-b718-a57287ecd915

License:

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

History

Date received : 27 January 2021

Date accepted : 29 January 2021

Funding

Funded by: Atopy ∙ Asthma Education Information Center;

Funded by: Korea Disease Control and Prevention Agency;

Gyeonggi-do Atopy · Asthma Education Information Center in Korea: a key partner in the Korean Asthma Allergy Program

Read this article at

Abstract

Related collections

Journal of Applied Computing and Information Technology

Most cited references 17

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

A 10 year asthma programme in Finland: major change for the better.

Epidemiology of adult asthma in Asia: toward a better understanding

Author and article information

Journal

Affiliations

Author notes

Author information

Article

History

Funding

Categories

Comments

Comment on this article

Similar content 70

Most referenced authors 2,610